Evidence map›Paper›PMID 22638814›Full record

ReviewPsychopharmacology2013

Learning to forget: manipulating extinction and reconsolidation processes to treat addiction.

Mary M Torregrossa, Jane R Taylor

Abstract readReview
In one paragraph

Review in Psychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Isradipine augmentation of virtual reality cue exposure therapy for tobacco craving: a triple-blind randomized controlled trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mary M TorregrossaDepartment of Psychiatry, Division of Molecular Psychiatry, S301, Yale University School of Medicine, Connecticut Mental Health Center, Ribicoff Research Laboratories, 34 Park St., New Haven, CT 06508, USA. mtorregrossa@gmail.com
Jane R Taylor

Funding

Translational Research of Cocaine, Striatum, and ImpulsivitiesP20DA027844 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2010 to 2013
$3.6M
COGNITIVE DYSFUNCTION AFTER CHRONIC PCP, THC AND COCAINER01DA011717 · NIDA · YALE UNIVERSITY · PI TAYLOR, JANE R · 1998 to 2014
$3.4M
Incentive Motivation in Addiction: PKA MechanismsR01DA015222 · NIDA · YALE UNIVERSITY · PI TAYLOR, JANE R · 2003 to 2013
$2.7M
Phosphoproteomics of Extinction and Reconsolidation of Drug MemoriesK01DA031745 · NIDA · YALE UNIVERSITY · PI TORREGROSSA, MARY M · 2011 to 2015
$758k
NIDA NIH HHS K01 DA031745NIDA NIH HHS P20 DA027844NIDA NIH HHS R01 DA011717NIDA NIH HHS R01 DA015222
6 · The paper itself

Abstract

Finding effective long-lasting treatments for drug addiction has been an elusive goal. Consequently, researchers are beginning to investigate novel treatment strategies including manipulations of drug-associated memories. When environmental stimuli (cues) become associated with drug use, they become powerful motivators of continued drug use and relapse after abstinence. Reducing the strength of these cue-drug memories could decrease the number of factors that induce craving and relapse to aid in the treatment of addiction. Enhancing the consolidation of extinction learning and/or disrupting cue-drug memory reconsolidation are two strategies that have been proposed to reduce the strength of cues in motivating drug-seeking and drug-taking behavior. Here, we review the latest basic and clinical research elucidating the mechanisms underlying consolidation of extinction and reconsolidation of cue-drug memories in the hopes of developing pharmacological tools that exploit these signaling systems to treat addiction.

Indexed as

AnimalsBehavior, AddictiveCuesExtinction, PsychologicalHumansMemoryMotivationSecondary PreventionSubstance-Related DisordersTime Factors

Identifiers

PMID22638814
PMCPMC3466391

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.